Vanguard Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.7B Buy
137,134,110
+2,545,381
+2% +$273M 0.24% 63
2025
Q1
$13.6B Buy
134,588,729
+1,697,945
+1% +$171M 0.25% 68
2024
Q4
$11.9B Buy
132,890,784
+1,600,062
+1% +$143M 0.21% 79
2024
Q3
$11B Buy
131,290,722
+1,420,249
+1% +$119M 0.2% 85
2024
Q2
$10B Buy
129,870,473
+2,432,589
+2% +$187M 0.19% 88
2024
Q1
$8.73B Buy
127,437,884
+1,988,082
+2% +$136M 0.17% 102
2023
Q4
$7.25B Buy
125,449,802
+1,681,454
+1% +$97.2M 0.16% 108
2023
Q3
$6.53B Buy
123,768,348
+1,525,432
+1% +$80.5M 0.16% 109
2023
Q2
$6.61B Buy
122,242,916
+1,999,170
+2% +$108M 0.16% 106
2023
Q1
$6.02B Buy
120,243,746
+1,469,952
+1% +$73.5M 0.15% 117
2022
Q4
$5.5B Buy
118,773,794
+1,887,558
+2% +$87.3M 0.15% 124
2022
Q3
$4.53B Buy
116,886,236
+1,708,496
+1% +$66.2M 0.13% 141
2022
Q2
$4.29B Buy
115,177,740
+1,812,913
+2% +$67.6M 0.12% 155
2022
Q1
$5.02B Buy
113,364,827
+1,743,197
+2% +$77.2M 0.12% 154
2021
Q4
$4.74B Buy
111,621,630
+408,827
+0.4% +$17.4M 0.11% 176
2021
Q3
$4.83B Buy
111,212,803
+1,077,710
+1% +$46.8M 0.12% 147
2021
Q2
$4.71B Buy
110,135,093
+305,405
+0.3% +$13.1M 0.12% 149
2021
Q1
$4.24B Sell
109,829,688
-951,470
-0.9% -$36.8M 0.11% 150
2020
Q4
$3.98B Sell
110,781,158
-1,224,828
-1% -$44M 0.12% 153
2020
Q3
$4.28B Sell
112,005,986
-1,114,056
-1% -$42.6M 0.14% 123
2020
Q2
$3.97B Buy
113,120,042
+1,393,290
+1% +$48.9M 0.14% 129
2020
Q1
$3.65B Buy
111,726,752
+2,709,903
+2% +$88.4M 0.16% 118
2019
Q4
$4.93B Buy
109,016,849
+913,742
+0.8% +$41.3M 0.17% 107
2019
Q3
$4.4B Buy
108,103,107
+1,231,208
+1% +$50.1M 0.16% 113
2019
Q2
$4.59B Buy
106,871,899
+1,649,632
+2% +$70.9M 0.17% 101
2019
Q1
$4.04B Buy
105,222,267
+1,381,019
+1% +$53M 0.16% 111
2018
Q4
$3.67B Buy
103,841,248
+2,387,890
+2% +$84.4M 0.16% 105
2018
Q3
$3.91B Buy
101,453,358
+1,367,053
+1% +$52.6M 0.15% 117
2018
Q2
$3.27B Buy
100,086,305
+1,576,173
+2% +$51.5M 0.14% 131
2018
Q1
$2.69B Buy
98,510,132
+1,830,157
+2% +$50M 0.12% 172
2017
Q4
$2.4B Buy
96,679,975
+1,442,815
+2% +$35.8M 0.1% 193
2017
Q3
$2.78B Buy
95,237,160
+1,579,860
+2% +$46.1M 0.13% 141
2017
Q2
$2.6B Buy
93,657,300
+2,522,556
+3% +$69.9M 0.13% 149
2017
Q1
$2.27B Buy
91,134,744
+3,503,965
+4% +$87.1M 0.12% 168
2016
Q4
$1.9B Buy
87,630,779
+1,802,661
+2% +$39M 0.11% 187
2016
Q3
$2.04B Buy
85,828,118
+3,065,345
+4% +$73M 0.12% 164
2016
Q2
$1.93B Sell
82,762,773
-15,437,741
-16% -$361M 0.12% 169
2016
Q1
$1.85B Buy
98,200,514
+3,263,402
+3% +$61.4M 0.12% 163
2015
Q4
$1.75B Buy
94,937,112
+2,753,185
+3% +$50.8M 0.12% 164
2015
Q3
$1.51B Buy
92,183,927
+2,399,761
+3% +$39.4M 0.11% 180
2015
Q2
$1.59B Sell
89,784,166
-13,609,498
-13% -$241M 0.11% 188
2015
Q1
$1.84B Buy
103,393,664
+1,694,252
+2% +$30.1M 0.12% 162
2014
Q4
$1.35B Buy
101,699,412
+3,979,591
+4% +$52.7M 0.1% 218
2014
Q3
$1.15B Buy
97,719,821
+2,310,917
+2% +$27.3M 0.09% 235
2014
Q2
$1.22B Buy
95,408,904
+3,182,718
+3% +$40.6M 0.1% 217
2014
Q1
$1.25B Buy
92,226,186
+2,567,778
+3% +$34.7M 0.1% 195
2013
Q4
$1.08B Buy
89,658,408
+2,636,953
+3% +$31.7M 0.09% 221
2013
Q3
$1.02B Buy
87,021,455
+2,476,318
+3% +$29.1M 0.1% 202
2013
Q2
$784M Buy
+84,545,137
New +$784M 0.08% 263